Almost 100% of people diagnosed with non-melanoma skin cancer survive for 5 years after being diagnosed. That's according to ...

A new report shows good news for skin cancer patients with most people (close to 100 per cent) surviving at least five years ...

So, MITF has a crucial lineage-survival function in melanoma, but does it influence a patient's response to chemotherapy? The authors carried out a supervised analysis of the pharmacological data ...

This is called secondary liver cancer or liver metastases. The terms 1 year, 4 year or 5 year survival don't mean that you will only live for 1 or 4 or 5 years. Organisations such as NHS Digital and ...

Metastatic melanoma ranks 5 th in new cases among cancers and the 5-year overall survival rate was 22.5% in 2018 according to the Melanoma Research Alliance. Current treatments for metastatic melanoma ...

Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...

Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option. First ...

"Five years on, and despite the reduced use of chemotherapy in patients who had liquid biopsies, survival outcomes in ... therapy in stage II colon cancer: 5-year outcomes of the randomized ...